Biomanufacturing, Biopharmaceutical, Health
The and and have entered into a collaboration agreement to develop a US-specific roadmap for the biopharmaceutical manufacturing industry. The roadmap will complement the existing BPOG global roadmap.
The US-specific Roadmap will focus on economic, regulatory, workforce development, and research challenges facing the US biopharmaceutical manufacturing industry. It will also address NIIMBL鈥檚 interests in both existing products (antibodies, proteins, vaccines, etc.) and emerging products (gene and cell therapies, exosomes, etc.)